The U.K. government is committing £21 million ($26.75 million) to help National Health Service trusts bring AI tools into hospitals. The funding is intended to speed up deployment of imaging and decision-support systems that could help clinicians diagnose and treat patients.
Funding for clinical AI tools
Called the AI Diagnostic Fund, the initiative will support NHS trusts seeking to deploy AI diagnostic tools. The government says trusts can apply for funding for any tool they consider suitable, but applications will need to explain why the spending represents value for money.
The fund is aimed at tools that assist with medical imaging and clinical decisions. The stated areas of focus include heart conditions, cancer and strokes. That gives trusts room to propose tools suited to their needs while tying requests to the government’s broader diagnostic priorities.
Funding does not, by itself, mean that every proposed system will be adopted. Trusts must make a case for the tool they want to use. The application process therefore links public investment to a justification from the health service organizations seeking it.
Stroke care is an early priority
The government wants AI tools deployed across all NHS stroke networks by the end of this year. AI has already been used to support clinical decision-making in stroke care for several years, with the COVID-19 pandemic in 2020 prompting further use as it stretched the NHS to its limits.
In the early stages of stroke care, decision-support software can help speed assessment and treatment. Dr. Deb Lowe, national clinical director for stroke medicine at NHS England, said the software means patients get interventions quicker, reducing the likelihood of disability and saving the brains.
She also said there is real-world evidence of benefits for NHS patients. Her comments point to the practical aim of the planned rollout: helping care teams make timely decisions in a setting where rapid assessment and treatment are essential.
Imaging could support earlier detection
Another area under consideration is the use of AI to analyze chest X-rays. The government says this could help clinicians detect early signs of lung cancer, which is the leading cause of cancer-related deaths in the U.K. and kills more than 35,000 people each year.
That focus places imaging alongside decision support as a core part of the fund’s purpose. In both cases, AI is intended to assist clinicians: helping interpret scans or supporting decisions about care. The source does not specify which particular products or systems trusts will choose.
Giving trusts the ability to propose tools means the fund is not limited to one named application. Each trust will have to decide what it wants to deploy and explain the value of that choice. The result will depend on the applications and the tools trusts consider appropriate.
A wider push to expand AI
The NHS fund is part of a broader U.K. effort to position the country at the center of AI development. The government has also announced global summits, million-pound prizes for AI development, guidelines for technology companies, and a £100 million pot to develop AI models for areas including education and healthcare.
Earlier this month, Prime Minister Rishi Sunak announced that OpenAI, Google’s DeepMind and Anthropic would provide early or priority access to their AI models to support research into evaluation and safety. The diagnostic fund brings that wider interest in AI into a specific public-service setting: hospitals and clinical care.
The NHS has faced controversy over earlier AI-related work. In 2017, a U.K. data regulator ruled that a data-sharing partnership between the NHS and Google’s DeepMind broke privacy laws. A class-action lawsuit against Google was ultimately tossed out by a U.K. court earlier this year.
That history sits alongside the new funding announcement. The immediate proposal is to let NHS trusts seek support for diagnostic and decision-support tools, with value for money forming part of their case. How broadly the technology is adopted will depend on which applications trusts put forward and the decisions made through the funding process.